Cell Design Labs
SUCCESS STORIES
Producing cancer-fighting cell therapies, UCSF startup, Cell Design Labs Inc. was acquired by Gilead for $567M.
Zebrafish Aid Drug Discovery
SUCCESS STORIES
Zebrafish-to-patient approach at UCSF speeds search for childhood epilepsy treatments.
Okada's Lab Targets Novel 'Neoantigen'
SUCCESS STORIES
Hideho Okada's lab leads the way for new immunotherapy for deadly childhood brain cancer.
Vanda License Agreement
SUCCESS STORIES
$46M deal using CFTR activators to treat dry eye, constipation, kidney disease & more.
Pionyr to Target Cancer Cells
SUCCESS STORIES
$62M deal to focus on antibody treatments to boost immune cells to fight cancer

As part of our public mission, UC San Francisco strives to translate our scientific discoveries for public use and benefit. Whether it’s a new drug molecule, diagnostic, medical device or digital health application, our goal is to ensure the best new therapies and technologies can make their way to the patient as efficiently and safely as possible.

From Innovation...